Larimar Therapeutics, Inc. SEC filings LRMR
Larimar Therapeutics, Inc. has 696 filings in SEC EDGAR's recent list, going back to Aug 28, 2006. Its latest annual report, Form ARS, was filed on Apr 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 4, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 29, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 4, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| 10-Q | Quarterly report | Nov 5, 2025 | Sep 30, 2025 |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 10-Q | Quarterly report | Apr 30, 2025 | Mar 31, 2025 |
| 10-Q | Quarterly report | Oct 30, 2024 | Sep 30, 2024 |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 10-Q | Quarterly report | Nov 14, 2023 | Sep 30, 2023 |
| 10-Q | Quarterly report | Aug 10, 2023 | Jun 30, 2023 |
| 10-Q | Quarterly report | May 15, 2023 | Mar 31, 2023 |
| 10-Q | Quarterly report | Nov 10, 2022 | Sep 30, 2022 |
| 10-Q | Quarterly report | Aug 11, 2022 | Jun 30, 2022 |
| 10-Q | Quarterly report | May 12, 2022 | Mar 31, 2022 |
| 10-Q | Quarterly report | Nov 12, 2021 | Sep 30, 2021 |
| 10-Q | Quarterly report | Aug 12, 2021 | Jun 30, 2021 |
| 10-Q | Quarterly report | May 10, 2021 | Mar 31, 2021 |
| 10-Q | Quarterly report | Nov 12, 2020 | Sep 30, 2020 |
| 10-Q | Quarterly report | Aug 14, 2020 | Jun 30, 2020 |
| 10-Q | Quarterly report | May 7, 2020 | Mar 31, 2020 |
| 10-Q | Quarterly report | Nov 6, 2019 | Sep 30, 2019 |
| 10-Q | Quarterly report | Aug 8, 2019 | Jun 30, 2019 |
| 10-Q | Quarterly report | May 9, 2019 | Mar 31, 2019 |
| 10-Q | Quarterly report | Nov 9, 2018 | Sep 30, 2018 |
| 10-Q | Quarterly report | Aug 9, 2018 | Jun 30, 2018 |
| 10-Q | Quarterly report | May 10, 2018 | Mar 31, 2018 |
| 10-Q | Quarterly report | Nov 7, 2017 | Sep 30, 2017 |
| 10-Q | Quarterly report | Aug 9, 2017 | Jun 30, 2017 |
| 10-Q | Quarterly report | May 9, 2017 | Mar 31, 2017 |
| 10-Q | Quarterly report | Nov 9, 2016 | Sep 30, 2016 |
| 10-Q | Quarterly report | Aug 5, 2016 | Jun 30, 2016 |
| 10-Q | Quarterly report | May 10, 2016 | Mar 31, 2016 |
| 10-Q | Quarterly report | Nov 13, 2015 | Sep 30, 2015 |
| 10-Q | Quarterly report | Aug 14, 2015 | Jun 30, 2015 |
| 10-Q | Quarterly report | May 14, 2015 | Mar 31, 2015 |
| 10-Q | Quarterly report | Nov 13, 2014 | Sep 30, 2014 |
| 10-Q | Quarterly report | Aug 14, 2014 | Jun 30, 2014 |
Showing 37 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- LRMR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Bala Cynwyd, PA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1374690
- Former names
- ZAFGEN, INC. (until May 19, 2020); ZAFGEN INC (until Nov 3, 2008)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.